Raymond James & Associates’s Varex Imaging VREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,042
Closed -$235K 4236
2022
Q1
$235K Buy
+11,042
New +$281K ﹤0.01% 3575
2020
Q2
Sell
-19,114
Closed -$434K 3672
2020
Q1
$434K Sell
19,114
-16,127
-46% -$415K ﹤0.01% 2511
2019
Q4
$1.05M Sell
35,241
-613
-2% -$18.3K ﹤0.01% 2239
2019
Q3
$1.02M Sell
35,854
-1,236
-3% -$35.8K ﹤0.01% 2192
2019
Q2
$1.14M Buy
37,090
+2,096
+6% +$64K ﹤0.01% 2140
2019
Q1
$1.19M Buy
34,994
+3,741
+12% +$113K ﹤0.01% 2097
2018
Q4
$740K Sell
31,253
-38,943
-55% -$989K ﹤0.01% 2277
2018
Q3
$2.01M Buy
70,196
+24,141
+52% +$794K ﹤0.01% 1810
2018
Q2
$1.71M Sell
46,055
-10,052
-18% -$372K ﹤0.01% 1865
2018
Q1
$2.01M Buy
+56,107
New +$2.14M ﹤0.01% 1699
2017
Q3
Sell
-13,188
Closed -$446K 3493
2017
Q2
$446K Sell
13,188
-5,750
-30% -$196K ﹤0.01% 2492
2017
Q1
$636K Buy
+18,938
New +$599K ﹤0.01% 2241

Other funds holding VREX

Raymond James & Associates's VREX Position: Q2 2022 in Review

Raymond James & Associates sold out of Varex Imaging (VREX) in Q2 2022, closing a stake of 11,042 shares — an estimated $235K sold.

Raymond James & Associates first reported a position in VREX in Q1 2017 and held it in 12 quarters. The position peaked at $2.01M in Q3 2018. 177 funds tracked by Wall St. Rank hold VREX as of Q2 2022.

  • Raymond James & Associates reported no remaining Varex Imaging position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 11,042 Varex Imaging shares in Q2 2022, an estimated $235K.
  • Raymond James & Associates first reported a position in Varex Imaging in Q1 2017 and held it in 12 quarters.
  • Raymond James & Associates's Varex Imaging position peaked at $2.01M in Q3 2018.
  • 177 funds tracked by Wall St. Rank held Varex Imaging as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.